| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 7
| Issue : 1 | Page : 3-7 |
|
|
Implications of the use of hydroxychloroquine on cardioactive drugs
Soumitra Ghosh1, Ashutosh Yadav2, Cliojis Francis3, Anunay Gupta3, Preeti Gupta3, Sourabh Agstam3
1 Department of Cardiology, PGIMER, Chandigarh, Punjab, India
2 Department of Cardiology, Fortis Hospital, Mohali, Punjab, India
3 Department of Cardiology, VMMC and Safdarjung Hospital, New Delhi, India
Correspondence Address:
Sourabh Agstam
Department of Cardiology, VMMC and Safdarjung Hospital, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpcs.jpcs_84_20
|
|
|
Hydroxychloroquine (HCQ) is a relatively safe drug, and has been emerged as one of the treatment options for the management of COVID-19. This review is from the viewpoint of cardiologists, and it covers the pharmacokinetics, pharmacodynamics, and mechanism of drug interaction of HCQ with the commonly used cardioactive drugs.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
